L LIQUIDIA CORPORATION
$37.68
| Market Cap | $3.32B |
| P/E Ratio | — |
| Forward P/E | 7.19 |
| Dividend Yield | — |
| Beta | 0.46 |
| 52W Range | $11.99 - $46.63 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Polen Capital Management Polen Capital Management | 0.00% | $1.16M | 33,538 | Buy |
Insider Trading
| Insider Name of the company insider who made the trade 64 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Stephen M BlochDirector | Sale | 1,973 | $37.13 | $73.26K | 27 Mar 2026 | 30 Mar 2026 |
| Stephen M BlochDirector | Sale | 30,176 | $36.38 | $1.10M | 27 Mar 2026 | 30 Mar 2026 |
| Stephen M BlochDirector | Sale | 30,401 | $35.42 | $1.08M | 27 Mar 2026 | 30 Mar 2026 |
| Stephen M BlochDirector | Sale | 7,684 | $37.22 | $285.99K | 26 Mar 2026 | 30 Mar 2026 |
| Moomaw ScottChief Commercial Officer | Sale | 17,000 | $36.81 | $625.82K | 23 Mar 2026 | 23 Mar 2026 |
| Moomaw ScottChief Commercial Officer | Sale | 1,314 | $36.48 | $47.93K | 23 Mar 2026 | 23 Mar 2026 |
| Krepp SarahChief Human Resource Officer | Sale | 16,261 | $38.00 | $617.92K | 13 Mar 2026 | 13 Mar 2026 |
| SINGH RAMAN | Sale | 20,000 | $36.04 | $720.83K | 13 Mar 2026 | 13 Mar 2026 |
| Saggar RajeevChief Medical Officer | Sale | 35,365 | $36.30 | $1.28M | 13 Mar 2026 | 13 Mar 2026 |
| Moomaw ScottChief Commercial Officer | Sale | 80,000 | $35.32 | $2.83M | 09 Mar 2026 | 09 Mar 2026 |
| Schundler RussellGeneral Counsel | Sale | 1,073 | $30.58 | $32.81K | 02 Mar 2026 | 03 Mar 2026 |
| Krepp SarahChief Human Resource Officer | Sale | 276 | $30.58 | $8.44K | 02 Mar 2026 | 03 Mar 2026 |
| Kaseta MichaelCFO and COO | Sale | 1,165 | $30.58 | $35.63K | 02 Mar 2026 | 03 Mar 2026 |
| Moomaw ScottChief Commercial Officer | Sale | 827 | $30.58 | $25.29K | 02 Mar 2026 | 03 Mar 2026 |
| Boyle DanaChief Accounting Officer | Sale | 445 | $30.58 | $13.61K | 02 Mar 2026 | 03 Mar 2026 |
| Adair JasonChief Business Officer | Sale | 689 | $30.58 | $21.07K | 02 Mar 2026 | 03 Mar 2026 |
| Adair JasonChief Business Officer | Sale | 688 | $41.65 | $28.66K | 26 Jan 2026 | 28 Jan 2026 |
| Boyle DanaChief Accounting Officer | Sale | 1,580 | $41.65 | $65.81K | 26 Jan 2026 | 28 Jan 2026 |
| Moomaw ScottChief Commercial Officer | Sale | 20,533 | $37.43 | $768.55K | 12 Jan 2026 | 13 Jan 2026 |
| Boyle DanaChief Accounting Officer | Sale | 11,047 | $37.43 | $413.49K | 12 Jan 2026 | 13 Jan 2026 |
| Kaseta MichaelCFO and COO | Sale | 36,932 | $37.43 | $1.38M | 12 Jan 2026 | 13 Jan 2026 |
| Saggar RajeevChief Medical Officer | Sale | 21,142 | $37.43 | $791.35K | 12 Jan 2026 | 13 Jan 2026 |
| JEFFS ROGERChief Executive Officer | Sale | 66,610 | $37.43 | $2.49M | 12 Jan 2026 | 13 Jan 2026 |
| Schundler RussellGeneral Counsel | Sale | 27,289 | $37.43 | $1.02M | 12 Jan 2026 | 13 Jan 2026 |
| Adair JasonChief Business Officer | Sale | 13,548 | $37.43 | $507.10K | 12 Jan 2026 | 13 Jan 2026 |
| Krepp SarahChief Human Resource Officer | Sale | 13,165 | $37.43 | $492.77K | 12 Jan 2026 | 13 Jan 2026 |
| Boyle DanaChief Accounting Officer | Sale | 303 | $32.19 | $9.75K | 01 Dec 2025 | 02 Dec 2025 |
| Moomaw ScottChief Commercial Officer | Sale | 831 | $32.19 | $26.75K | 01 Dec 2025 | 02 Dec 2025 |
| Adair JasonChief Business Officer | Sale | 693 | $32.19 | $22.31K | 01 Dec 2025 | 02 Dec 2025 |
| Schundler RussellGeneral Counsel | Sale | 1,072 | $32.19 | $34.51K | 01 Dec 2025 | 02 Dec 2025 |
| Kaseta MichaelCFO and COO | Sale | 1,166 | $32.19 | $37.53K | 01 Dec 2025 | 02 Dec 2025 |
| Krepp SarahChief Human Resource Officer | Sale | 221 | $32.19 | $7.11K | 01 Dec 2025 | 02 Dec 2025 |
| Russell SchundlerGeneral Counsel | Sale | 1,072 | $32.19 | $34.51K | 01 Dec 2025 | 02 Dec 2025 |
| Scott MoomawChief Commercial Officer | Sale | 831 | $32.19 | $26.75K | 01 Dec 2025 | 02 Dec 2025 |
| Dana BoyleChief Accounting Officer | Sale | 303 | $32.19 | $9.75K | 01 Dec 2025 | 02 Dec 2025 |
| Sarah KreppChief Human Resource Officer | Sale | 221 | $32.19 | $7.11K | 01 Dec 2025 | 02 Dec 2025 |
| Michael KasetaCFO and COO | Sale | 1,166 | $32.19 | $37.53K | 01 Dec 2025 | 02 Dec 2025 |
| Jason AdairChief Business Officer | Sale | 693 | $32.19 | $22.31K | 01 Dec 2025 | 02 Dec 2025 |
| Adair JasonChief Business Officer | Sale | 35,656 | $30.03 | $1.07M | 18 Nov 2025 | 20 Nov 2025 |
| Jason AdairChief Business Officer | Sale | 35,656 | $30.03 | $1.07M | 18 Nov 2025 | 20 Nov 2025 |
| Boyle DanaChief Accounting Officer | Sale | 20,662 | $25.06 | $517.79K | 07 Nov 2025 | 12 Nov 2025 |
| Boyle DanaChief Accounting Officer | Sale | 8,342 | $25.16 | $209.88K | 07 Nov 2025 | 12 Nov 2025 |
| Saggar RajeevChief Medical Officer | Sale | 66,463 | $27.00 | $1.79M | 05 Nov 2025 | 07 Nov 2025 |
| Saggar RajeevChief Medical Officer | Sale | 4,918 | $27.00 | $132.79K | 05 Nov 2025 | 07 Nov 2025 |
| Adair JasonChief Business Officer | Sale | 692 | $22.93 | $15.87K | 27 Oct 2025 | 29 Oct 2025 |
| Boyle DanaChief Accounting Officer | Sale | 1,073 | $22.93 | $24.60K | 27 Oct 2025 | 29 Oct 2025 |
| Jason AdairChief Business Officer | Sale | 692 | $22.93 | $15.87K | 27 Oct 2025 | 29 Oct 2025 |
| Dana BoyleChief Accounting Officer | Sale | 1,073 | $22.93 | $24.60K | 27 Oct 2025 | 29 Oct 2025 |
| Moomaw ScottChief Commercial Officer | Sale | 4,900 | $23.41 | $114.71K | 13 Oct 2025 | 15 Oct 2025 |
| Schundler RussellGeneral Counsel | Sale | 7,839 | $23.41 | $183.51K | 13 Oct 2025 | 15 Oct 2025 |
| Krepp SarahChief Human Resource Officer | Sale | 1,691 | $23.41 | $39.59K | 13 Oct 2025 | 15 Oct 2025 |
| Adair JasonChief Business Officer | Sale | 3,670 | $23.41 | $85.91K | 13 Oct 2025 | 15 Oct 2025 |
| Saggar RajeevChief Medical Officer | Sale | 5,327 | $23.41 | $124.71K | 13 Oct 2025 | 15 Oct 2025 |
| Boyle DanaChief Accounting Officer | Sale | 1,238 | $23.41 | $28.98K | 13 Oct 2025 | 15 Oct 2025 |
| JEFFS ROGERChief Executive Officer | Sale | 20,261 | $23.41 | $474.31K | 13 Oct 2025 | 15 Oct 2025 |
| Kaseta MichaelCFO and COO | Sale | 11,630 | $23.41 | $272.26K | 13 Oct 2025 | 15 Oct 2025 |
| Russell SchundlerGeneral Counsel | Sale | 7,839 | $23.41 | $183.51K | 13 Oct 2025 | 15 Oct 2025 |
| Michael KasetaCFO and COO | Sale | 11,630 | $23.41 | $272.26K | 13 Oct 2025 | 15 Oct 2025 |
| Scott MoomawChief Commercial Officer | Sale | 4,900 | $23.41 | $114.71K | 13 Oct 2025 | 15 Oct 2025 |
| Rajeev SaggarChief Medical Officer | Sale | 5,327 | $23.41 | $124.71K | 13 Oct 2025 | 15 Oct 2025 |
| Dana BoyleChief Accounting Officer | Sale | 1,238 | $23.41 | $28.98K | 13 Oct 2025 | 15 Oct 2025 |
| Roger JeffsChief Executive Officer | Sale | 20,261 | $23.41 | $474.31K | 13 Oct 2025 | 15 Oct 2025 |
| Jason AdairChief Business Officer | Sale | 3,670 | $23.41 | $85.91K | 13 Oct 2025 | 15 Oct 2025 |
| Sarah KreppChief Human Resource Officer | Sale | 1,691 | $23.41 | $39.59K | 13 Oct 2025 | 15 Oct 2025 |
Frequently Asked Questions
What is LQDA stock price today?
LIQUIDIA CORPORATION (LQDA) is currently trading at $37.68. The stock has a 52-week range of $11.99 to $46.63 and a market capitalization of $3.32B.
Is LQDA a good stock to buy in 2026?
LIQUIDIA CORPORATION has a P/E ratio of N/A (forward P/E: 7.2), a dividend yield of none, and 1-year performance of +166.7%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling LQDA stock?
There have been 64 insider transactions for LQDA in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has LQDA stock performed over the past year?
LIQUIDIA CORPORATION (LQDA) has returned +166.7% over the past 12 months. The stock traded between $11.99 and $46.63 during this period, and is currently at $37.68.
Which hedge funds own LQDA (LIQUIDIA CORPORATION)?
1 tracked hedge funds currently hold LQDA in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is LQDA's market cap and valuation?
LIQUIDIA CORPORATION (LQDA) has a market capitalization of $3.32B. The trailing P/E ratio is N/A and forward P/E is 7.2. The stock is classified in the Healthcare sector.
What is LQDA's revenue and profitability?
LIQUIDIA CORPORATION reported revenue of $158.32M with net income of N/A and a profit margin of N/A. The stock has a beta of 0.46.
What sector is LQDA in and who are its biggest institutional holders?
LIQUIDIA CORPORATION (LQDA) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.